All Stories

  1. Real-world use of osimertinib in non–small cell lung cancer: ASTRIS study Korean subgroup analysis

    Article • Current Medical Research and Opinion, October 2019, Taylor & Francis

    Keunchil Park, Sung-Yong Lee

  2. Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations

    Article • Cancer Science, August 2018, Wiley

    Keunchil Park

  3. Characteristics and outcomes of ALK + non-small cell lung cancer patients in Korea

    Article • Asia-Pacific Journal of Clinical Oncology, April 2017, Wiley

    Keunchil Park, Sung Hee Lim

  4. Prospects and progress of atezolizumab in non-small cell lung cancer

    Article • Expert Opinion on Biological Therapy, March 2017, Taylor & Francis

    Keunchil Park